Overview

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Status:
Terminated
Trial end date:
2015-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BMS-813160 will reduce the amount of protein loss in the urine of subjects with type 2 diabetes and diabetic kidney disease
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb